Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar

Completed · Phase 3

Conditions studied: Bipolar Disorder

In brief

The study is to examine the null hypothesis that risperidone and divalproex sodium are equally effective in treating/stabilizing pediatric bipolar disorder.

Key facts

Study ID

NCT00176202

Run by

University of Illinois at Chicago

People needed

65

Starts

2003-04-01

Expected to finish

2008-01-01

Last updated by the study team

2015-11-05

Who can join

Age: 10 and older, up to 20. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Children with Bipolar Disorder
• Must be able to swallow tablets

You may not qualify if…

• Children with general medical condition such as head injury, epilepsy, endocrine disorders
• Those who are on mood altering medications such as steroids, and those diagnosed with mental retardation are excluded to avoid confounding and contributing factors to mood swings.
• If we discover during the interview that the parent and/or child does not understand the consent/assent procedures, we will exclude them.
• We expect only a small number of children to be excluded from the study due to exclusionary criteria. Selection of the subjects is not based on sex, race, or ethnic group.

Where it is running

• Neuro Psychiatric Institute (NPI) — Chicago, Illinois, United States
• NPI, University of Illinois at Chicago — Chicago, Illinois, United States
• NPI — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.